KT&G Reports 1% Increase in Q2 Operating Profit

Aug.08.2022
KT&G Reports 1% Increase in Q2 Operating Profit
KT&G reported a 1% YoY increase in Q2 2022 consolidated operating profit at KRW 3276 billion.

In its financial report, Korea Tobacco & Ginseng Corporation (KT&G for short) stated that its second quarter comprehensive operating profit in 2022 was 327.6 billion Korean won ($249.7 million USD), which is a 1% year-over-year increase.


The KT&G building, sourced from KT&G.


During the period from April to June, the revenue was 1.42 trillion Korean won, an increase of 10.9% compared to the same period last year, with a net profit growth of 34% to 330.1 billion Korean won.


The company stated that its sales have increased, thanks to active overseas sales and the profitability of its real estate ventures.


The international sales of the company's traditional cigarette business increased by a remarkable 47.1%, largely due to growth in Latin America and other emerging markets, as well as improved sales performance in Indonesia.


KT&G's market share for heated tobacco products (HnB) in South Korea increased from 40.4% in 2021 to 47% in 2022. According to KT&G's data, HnB products now represent 16.7% of all tobacco sales in South Korea.


A company official stated that despite rising interest rates and soaring commodity prices, KT&G's traditional and vapor businesses will continue to experience robust growth in the coming months.


Statement:


This article is compiled from third-party information and is for industry professionals to exchange and learn insights.


This article does not represent the views of 2FIRSTS and we cannot confirm the authenticity and accuracy of its content. The translation of this article is solely for internal communication and research within the industry.


Due to limitations in translation capability, the translated article may not fully convey the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, and foreign issues, statements, and positions.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Cyprus Ranks Among Europe’s Highest for Teen Vaping, Expert Warns Nicotine Risks Are Being Underestimated
Cyprus Ranks Among Europe’s Highest for Teen Vaping, Expert Warns Nicotine Risks Are Being Underestimated
An opinion piece by Cyprus-based expert Dr. Angelos Kassianos argues that while traditional teen smoking is declining across Europe, vaping is rising rapidly—and Cyprus stands out with high usage levels, including around one in ten 16-year-olds vaping daily.
Jan.28 by 2FIRSTS.ai
Belarus opts for stricter regulation instead of full e-cigarette ban
Belarus opts for stricter regulation instead of full e-cigarette ban
Belarus rejects full e-cigarette ban, opts for stricter regulation. Officials plan to restrict wholesaling and strengthen import and production permits.
Mar.04 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
Kazakhstan’s Almaty crackdown: Telegram channels used to sell banned vapes, six face charges
Kazakhstan’s Almaty crackdown: Telegram channels used to sell banned vapes, six face charges
Authorities in Almaty have uncovered a large illegal vape distribution scheme, seizing and destroying more than 180,000 vapes. Prosecutors said potential revenue from sales could have exceeded 1 billion tenge. Suspects allegedly sold the banned products through Telegram channels and social media, storing inventory in warehouses and covert locations.
Feb.27 by 2FIRSTS.ai
2Firsts Holds Second PMTA Compliance Training in Shenzhen, Highlighting U.S. Regulatory Framework and Corporate Compliance Capabilities
2Firsts Holds Second PMTA Compliance Training in Shenzhen, Highlighting U.S. Regulatory Framework and Corporate Compliance Capabilities
2Firsts held its second U.S. PMTA compliance training in Shenzhen, providing a systematic overview of the U.S. regulatory framework for e-cigarettes and corporate compliance strategies. Nearly 20 industry professionals from manufacturing, e-liquid and supply-chain companies attended. Participants who passed the exam received compliance certification. Registration for the third training session will open soon, alongside customized corporate training programs.
Mar.09
Before the Boom:  Why Manufacturing Is Becoming the Deciding Factor in U.S. Nicotine Pouches — An Interview with Rena World
Before the Boom: Why Manufacturing Is Becoming the Deciding Factor in U.S. Nicotine Pouches — An Interview with Rena World
As the U.S. nicotine pouch market moves toward regulatory clarity and rapid growth, attention is shifting from demand to execution. In an interview with 2Firsts, U.S.-based manufacturer Rena explains why manufacturing capacity, quality systems, and compliance readiness are becoming decisive factors before the market fully takes off.
Jan.19